Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia
about
Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgerySarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?Radiologically Determined Sarcopenia Predicts Morbidity and Mortality Following Abdominal Surgery: A Systematic Review and Meta-AnalysisInfluence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic CancerHuman pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer.The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Impact of preoperative hand grip strength on morbidity following gastric cancer surgery.Pre-operative volume rather than area of skeletal muscle is a better predictor for post-operative risks for respiratory complications in living-donor liver transplantation.Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.Clinical and morphometric parameters of frailty for prediction of mortality following hepatopancreaticobiliary surgery in the elderly.Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer.Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.A semi-automated assessment of sarcopenia using psoas area and density predicts outcomes after pancreaticoduodenectomy for pancreatic malignancy.Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma.Can Comprehensive Imaging Analysis with Analytic Morphomics and Geriatric Assessment Predict Serious Complications in Patients Undergoing Pancreatic Surgery?Preoperative Sarcopenia Strongly Influences the Risk of Postoperative Pancreatic Fistula Formation After Pancreaticoduodenectomy.Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.Psoas Muscle Size Predicts Risk-Adjusted Outcomes After Surgical Aortic Valve ReplacementLongitudinal CT study of sarcopenia due to hepatic failure after living donor liver transplantation.Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
P2860
Q26827248-C2D85D99-EBF2-431E-857F-488E23C6AEBDQ28079809-418FF866-EAB5-4DDA-9D8B-45A8FB53ECD3Q29994656-F5BADFAD-9429-4A12-B7A5-800AA4831608Q35970523-169BA92D-4B92-4380-8B78-FFE8960B008CQ37528758-3220FAC9-602F-41BA-A017-D019D21074FDQ37702064-4493FC38-1220-4B35-8C78-26EFDD019CA1Q37717197-95C3A7AB-47DC-4E61-B046-4B4D6C30425DQ38672321-4F3B6056-7C04-426B-962F-74135D00D531Q38842194-9B085BBE-3CA8-4531-A209-E14229407FF3Q38953534-9C2BABAD-7842-4F37-BA6A-4A0076AAC493Q38970130-0D3C8AED-1365-4B57-B25A-433E762E3A4CQ39450412-9AE37CE2-45F5-49A4-A393-248826B4371DQ40278429-FA03D114-0069-4038-8551-3C54EDEDB8CEQ41485323-11F2EAAC-F421-4D2B-A400-14C07EE076E4Q43434762-07E41F03-F168-4950-B9CF-9AA234326093Q47272245-77040B49-9775-44A6-BA56-3AE456A61D00Q47801764-CCA1945A-8B57-4CB3-8571-AE6E2CC8AB5AQ48136772-4D930DD9-74BE-43B3-BEC5-192A9B4EA769Q48370859-BA4C9170-A4B4-4C06-BB2B-4389555A0EC4Q50239119-6006DD22-C517-4785-ABE2-558F58C1D759Q52947322-1A1455B1-DA19-421B-808F-7CF1B99309B1Q52983311-2DB9F47D-6672-4FD9-91C6-6D35EB98EFAEQ54918451-C1EFFCD5-5F61-404E-87F4-82C685DB9623Q54965039-822C11B1-988F-4904-8F45-8F607D59F701Q54997581-72A4E803-AD0E-4028-8CEA-1B663380DCAAQ55230621-D0F7FB2C-8B9D-4DCD-A50C-E724F8F22F83Q55420024-8D4F22E4-DEF2-48A8-81A6-E90FC58AF830
P2860
Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact Total Psoas Volume on S ...... New Tool to Assess Sarcopenia
@en
type
label
Impact Total Psoas Volume on S ...... New Tool to Assess Sarcopenia
@en
prefLabel
Impact Total Psoas Volume on S ...... New Tool to Assess Sarcopenia
@en
P2093
P2860
P1476
Impact Total Psoas Volume on S ...... New Tool to Assess Sarcopenia
@en
P2093
Christopher L Wolfgang
Doris Wagner
Gaya Spolverato
Georgios A Margonis
Ihab R Kamel
Martin M Makary
Matthew J Weiss
Neda Amini
Neda Rezaee
Rohan Gupta
P2860
P2888
P304
P356
10.1007/S11605-015-2835-Y
P577
2015-04-30T00:00:00Z